Devices and methods for monitoring an analyte

Details Devices and methods for monitoring an analyte Devices and methods for monitoring an analyte

2001-04-11

2002-09-24

Shaver, Kevin (Department: 3736)

Surgery

Diagnostic testing

Measuring or detecting nonradioactive constituent of body...

C600S316000, C600S317000, C600S322000, C204S403060, C204S415000

Reexamination Certificate

active

06454710

ABSTRACT:

BACKGROUND
The present invention relates to devices and methods for monitoring an analyte and, more particularly, to devices and methods for transdermal monitoring of an analyte.
The monitoring of certain analyte concentrations in the body enables early detection of health risks, and identifies the need for the introduction of therapeutic measures. One of the most commonly monitored analytes is glucose. The concentration of glucose in the blood is an important parameter which determines the appropriate dosages of insulin for diabetics. Various methods have been developed for monitoring glucose levels in the blood, including methods conducted in vivo. For example, an implantable fluorescence affinity hollow fiber sensor has been reported for the continuous transdermal monitoring of glucose in the blood (see, for example,
Analytical Chemistry
Vol. 72, No. 17, pp. 4185-4192). The interiors of such hollow fiber sensors are packed with cross-linked dextran beads and fluorescently-tagged bioreagents that display fluorescence changes with rising concentrations of glucose. Detection of the fluorescence is achieved extracorporeally (e.g., with an optical unit incorporating a laser and a photodetector) and is correlated with a concentration of glucose in the blood.
Unfortunately, the use of hollow fiber sensors for monitoring glucose in the blood suffers from a number of drawbacks. First, due to the narrow width of the fibers (ca. 200 microns) and the unpredictable ratio of dextran bead volume to void volume, reproducible packing of the interiors is extremely difficult, and leads to irreproducibility of fluorescence readings between fibers. Second, the narrow cross-section of the fibers results in weak fluorescence signals which are difficult to detect. Third, the fibers are delicate and prone to kinks, which complicates both the implantation and explantation of the fibers in the subcutaneous tissue. Fourth, the mobility of the cross-linked dextran beads in the fiber can result in the interposition of a bead between the excitation light from the laser and a fluorescently-tagged bioreagent, thus resulting in reduced signal.
The present invention is directed to overcoming these and other disadvantages inherent in hollow fiber sensors.
SUMMARY
The scope of the present invention is defined solely by the appended claims, and is not affected to any degree by the statements within this summary.
Briefly stated, a device for monitoring an analyte embodying features of the present invention includes (a) a support having an interior surface and an exterior surface; (b) a substrate connected to the interior surface of the support, wherein the substrate is opaque; (c) a spacer connected to the interior surface of the support; (d) a labeled analogue, which binds reversibly to the substrate; and (e) a first membrane having an interior surface and an exterior surface, wherein the interior surface is connected to the spacer. The first membrane is permeable to the analyte and impermeable to the labeled analogue, and the first membrane is substantially transparent to each of an excitation wavelength and an emission wavelength of the fluorescent label. The dye absorbs a majority of the excitation and emission wavelengths of the fluorescent label. A chamber which encloses the substrate and the labeled analogue is defined by the interior surface of the support, the spacer, and the interior surface of the first membrane. The spacer exceeds the substrate in elevation such that a void volume exists between the interior surface of the first membrane and the substrate.
A method for monitoring an analyte embodying features of the present invention includes (a) implanting into a subcutaneous region of a patient a device in accordance with the present invention; (b) illuminating an extracutaneous region of the patient with a light having a wavelength which corresponds to the excitation wavelength of a fluorescently-labeled analogue contained in the device; (c) detecting a fluorescence signal corresponding to the emission wavelength of the fluorescently-labeled analogue using an extracutaneous photodetector; and (d) correlating the fluorescence signal with a concentration of the analyte.
The presently preferred embodiments described herein may possess one or more advantages relative to hollow fiber sensors, which can include but are but not limited to: higher fluorescence yields; reproducible introduction of bioreagents during manufacture of device; preservation of physical integrity of device during implantation and explantation; improved reproducible positioning of extracorporeal photodetector; significantly improved signal-to-noise ratio; and minimization of undesirable random fluorophore shadowing effects.


REFERENCES:
patent: 3877784 (1975-04-01), Lin
patent: 4058732 (1977-11-01), Wieder
patent: 4150295 (1979-04-01), Wieder
patent: 4344438 (1982-08-01), Schultz
patent: 4737464 (1988-04-01), McConnell et al.
patent: 4791310 (1988-12-01), Honig et al.
patent: 5061076 (1991-10-01), Hurley
patent: 5143066 (1992-09-01), Komives et al.
patent: 5156972 (1992-10-01), Issachar
patent: 5496997 (1996-03-01), Pope
patent: 5660848 (1997-08-01), Moo-Young
patent: 5756115 (1998-05-01), Moo-Young
patent: 5814449 (1998-09-01), Schultz et al.
patent: 5871628 (1999-02-01), Dabiri et al.
patent: 5990479 (1999-11-01), Weiss
patent: 5995860 (1999-11-01), Sun et al.
patent: 6002954 (1999-12-01), Van Antwerp et al.
patent: 6011984 (2000-01-01), Van Antwerp et al.
patent: 6110630 (2000-08-01), Reddy et al.
patent: 6114350 (2000-09-01), Randall et al.
patent: 6163714 (2000-12-01), Stanley et al.
patent: 6177684 (2001-01-01), Sugiyama
patent: 6256522 (2001-07-01), Schultz
patent: 0761159 A3 (1998-03-01), None
patent: WO 00/20862 (2000-04-01), None
Sohrab Mansouri and Jerome S. Schultz “A Miniature Optical Glucose Sensor On Affinity Binding”, Biotechnology, 1984, pp. 885-890.
W. Rudolf Seitz, “Optical Sensors Based In Immobilized Reagents”, Biosensors Fundamentals and Applications, Oxford University Press, copyright 1987, pp. 599-603.
D. L. Meadows and J. S. Schultz, “Design, Manufacture and Characterization of an Optical Fiber Glucose Affinity Sensor Based on An Homogeneous Fluorescence Energy Transfer Assay System”, Analytica Chimica Acta 280, 1993, pp. 21-30.
Klaus Mosbach and Olof Ramström, “The Emerging Technique of Molecular Imprinting and Its Future on Biotechnology”, Bio/Technology vol. 14, 1996, pp. 163-170.
Margaret A. Hines et al., Synthesis and Characterization of Strongly Liminescing ZnS-Capped CdSe Nanocrystals, J. Phys. Chem., 100, 1996, pp. 468-471.
Dmitri Ivnitski et al., “Biosensors for Detection of Pathogenic Bacteria”, Biosensors and Bioelectronics 14, 1999, pp. 599-624.
Ryan J. Russell et al., “A Flourecense-Based Glucose Biosensor Using Concanavalin A and Dextran Encapsulated In A Poly(ethylene glycol) Hydrogel”, Analytical Chemistry Vo. 71, No. 15, 1999, pp. 3126-3132.
M. Dittrich et al., “Branched Oligoester Microspheres Fabricated By A Rapid Emulsion Solvent Extraction Method”, J. Microencapsulation, vol. 17, No. 5, 2000, pp. 587-598.
J. Molpeceres et al., “Biodegradable Nanoparticles As A Delivery System For Cyclosporine: Preparation and Characterization”, J. Microencapsulation, vol. 17, No. 5, 2000, pp. 599-614.
Ralph Ballerstadt and Jerome S. Schultz, “A Fluorescence Affinity Hollow Fiber Sensor For Continuous Transdermal Glucose Monitoring”, Analytical Chemistry vol. 72, No. 17, 2000, pp. 4185-4192.
The Nut Factory: Kitchen: Interesting Facts: Chocolate Panning:, “Panning Nuts in Chocolate”, <http://www.the nutfactory.com/kitchen/facts-chocolate-panning.html>, Mar. 16, 2001, pp. 1-4.
John Franjione, Ph. D. et al.—Technology Today—Art & Science Microencapsulation, “The Art and Science of Microencapsulation”, <http://www.swri.org/3pubs/ttoday/summer/microeng.htm>, Mar. 16, 2002, pp. 1-7.

Affiliated with

Also associated with

Rating

Devices and methods for monitoring an analyte does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Devices and methods for monitoring an analyte, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Devices and methods for monitoring an analyte will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2886378